Fingerprint
Dive into the research topics of 'A phase 3 trial of bevacizumab in ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 3 trial of bevacizumab in ovarian cancer
Timothy J. Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S. Carey, Philip Beale, Andreś Cervantes, Christian Kurzeder, Andreas Du Bois, Jalid Sehouli, Rainer Kimmig, Anne Staḧle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Fred́eŕic Selle, Mansoor R. Mirza
*Corresponding author for this work
- St. James's Institute of Oncology
- St James's University Hospital
- Medical Research Council
- Städtischen Klinikum Solingen
- Klinik für Gynäkologie und Geburtshilfe
- University of London
- Université Paris Descartes
- University of Oslo
- Department of Obstetrics and Gynecology
- University of British Columbia
- Australia New Zealand Gynaecological Oncology Group
- Department of Radiation Oncology
- University of Valencia
- University of Ulm
- Dr. Horst Schmidt Klinik GmbH
- Charite - Universitatsmedizin Berlin
- University of Duisburg-Essen
- St. Vincentius Kliniken Karlsruhe
- St. Luke's Cancer Center
- Royal Brompton and Harefield NHS Foundation Trust
- Centre for Genomics and Experimental Medicine
- University of Edinburgh
- Centre Catherine de Sienne
- Hopital Tenon
- Department of Oncology
- Copenhagen University Hospital Rigshospitalet
- Women's Clinic
- University of Helsinki
- Department of Obstetrics and Gynecology
- Laval University
- Leeds Institute of Molecular Medicine
- Cambridge Cancer Trials Center
- University of Cambridge
- Princess Margaret Cancer Centre
950
Citations
(Scopus)